TLDR Smoking doesn't cause or prevent Frontal Fibrosing Alopecia, hormonal imbalance may be involved, and a combination of antiandrogens and steroids can help stabilize the condition.
The document is a reply to a letter regarding a study on Frontal Fibrosing Alopecia (FFA). The authors, Sergio Vaño-Galván and colleagues, address several points raised by Susan Holmes and Alison MacDonald. They clarify that smoking does not appear to trigger or protect against FFA, based on their study and Holmes and MacDonald's study. They suggest hormonal imbalance, particularly in postmenopausal women, may play a role in FFA's pathogenesis, but acknowledge that this does not explain all cases. They also discuss the difficulty in assessing treatment response, noting that while hair regrowth was minimal, stabilization of the condition was achieved in some patients. Specifically, they highlight that antiandrogenic drugs were used in 111 of 355 patients (31%), with stabilization observed in all cases and improvement in 28 patients (25.2%) who did not receive other treatments. They conclude that while spontaneous stabilization is possible, it is unlikely to account for all observed cases of stabilization. The authors agree with Holmes and MacDonald that randomized controlled trials with validated assessment tools are needed to confirm treatment efficacy, but in the meantime, a combination of antiandrogens and intralesional steroids seems to be an effective strategy for achieving stabilization in FFA patients.
102 citations,
April 2014 in “International Journal of Dermatology” The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.
339 citations,
February 2014 in “Journal of The American Academy of Dermatology” Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.
98 citations,
February 2013 in “Journal of The American Academy of Dermatology” Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.
166 citations,
April 2012 in “Journal of The American Academy of Dermatology” Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.
August 2019 in “Journal of the American Academy of Dermatology” Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.
339 citations,
February 2014 in “Journal of The American Academy of Dermatology” Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.
5 citations,
September 2021 in “Journal of The American Academy of Dermatology” Most men with Frontal fibrosing alopecia also lose facial hair and the condition may be linked to hormone levels and sunscreen use.
1 citations,
January 2024 in “Journal of personalized medicine” Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.
9 citations,
August 2014 in “Journal of The American Academy of Dermatology” Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.